Regulonix
PrivateLast Round
Seed
Jul 10, 2018
Total Funding Raised
$2M
Company Overview
Regulonix is a biotechnology company developing non-opioid therapeutics to relieve chronic pain by indirectly targeting the NaV1.7 sodium channel.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Regulonix Comparables
Compare Regulonix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Navega Therapeutics | 79% | |
| Eli Lilly and Company | 78% | |
| Latigo Biotherapeutics | 78% | |
Regulonix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 10, 2018 |
Regulonix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Desert Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 10, 2018
$2M round led by Uventurecap.
Regulonix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Regulonix's valuation, stock price, and market status.